Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.
about
Compstatin: a C3-targeted complement inhibitor reaching its prime for bedside intervention.The relative merits of therapies being developed to tackle inappropriate ('self'-directed) complement activationRefractory IgG Warm Autoimmune Hemolytic Anemia Treated with Eculizumab: A Novel Application of Anticomplement Therapy.Standardizing leucocyte PNH clone detection: an international study.
P2860
Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.
@en
type
label
Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.
@en
prefLabel
Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.
@en
P2860
P1476
Paroxysmal nocturnal hemoglobinuria and the age of therapeutic complement inhibition.
@en
P2093
Juan Carlos Varela
Robert A Brodsky
P2860
P304
P356
10.1586/1744666X.2013.842896
P577
2013-11-01T00:00:00Z